DRUG SAFETY ALERT FOR MEFTAL

MEFTAL, a combination medication featuring dicyclomine and mefenamic acid, serves as an anti-spasmodic used primarily to alleviate abdominal pain and spasms, especially during menstrual periods. This blog aims to provide a detailed overview, addressing common questions and concerns about MEFTAL.

1. What is MEFTAL?

MEFTAL is a medication combining dicyclomine and mefenamic acid. Dicyclomine helps relieve muscle spasms, while mefenamic acid offers pain relief. It is widely prescribed for conditions such as musculoskeletal pain, dysmenorrhea, arthritis, and postoperative pain.

2. How Does MEFTAL Help?

MEFTAL works by blocking specific chemicals responsible for pain and relaxing smooth muscles. The dual action of dicyclomine and mefenamic acid provides effective relief from abdominal pain and spasms associated with various conditions.

3. Chemical Composition

Dicyclomine: Acts as an anti-spasmodic by relaxing muscles in the gut.

Mefenamic Acid: Provides pain relief and reduces inflammation.

4. Why is MEFTAL Harmful?

While MEFTAL is generally considered safe when used as prescribed, recent safety concerns have emerged. The Indian Pharmacopoeia Commission (IPC) issued a drug safety alert, linking mefenamic acid to cases of DRESS syndrome. This severe allergic reaction can lead to multi-organ failure, emphasizing the need for caution.

5. Government News and Safety Concerns

The IPC's alert highlights adverse reactions associated with mefenamic acid, urging healthcare professionals and consumers to exercise caution. The ongoing investigation by the Indian drug regulator emphasizes the importance of staying informed about potential safety risks.

*Disclaimer: This blog provides general information and should not be considered medical advice. Consult your healthcare professional for personalized guidance.